BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12721945)

  • 1. Phagocytosis of Bordetella pertussis incubated with convalescent serum.
    Mobberley-Schuman PS; Connelly B; Weiss AA
    J Infect Dis; 2003 May; 187(10):1646-53. PubMed ID: 12721945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.
    Mobberley-Schuman PS; Weiss AA
    Infect Immun; 2005 Nov; 73(11):7317-23. PubMed ID: 16239529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.
    Weingart CL; Mobberley-Schuman PS; Hewlett EL; Gray MC; Weiss AA
    Infect Immun; 2000 Dec; 68(12):7152-5. PubMed ID: 11083845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
    Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
    Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.
    Weingart CL; Weiss AA
    Infect Immun; 2000 Mar; 68(3):1735-9. PubMed ID: 10679000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
    Chodorowska M
    Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic studies of the molecular basis of whooping cough.
    Weiss AA; Hewlett EL; Myers GA; Falkow S
    Dev Biol Stand; 1985; 61():11-9. PubMed ID: 2872097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.
    Cherry JD; Xing DX; Newland P; Patel K; Heininger U; Corbel MJ
    Clin Infect Dis; 2004 Feb; 38(4):502-7. PubMed ID: 14765342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.
    Colombi D; Horton DS; Oliveira ML; Sakauchi MA; Ho PL
    FEMS Microbiol Lett; 2004 Nov; 240(1):41-7. PubMed ID: 15500977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of serum anti-Bordetella pertussis antibody titers among medical staff members.
    Higa F; Haranaga S; Tateyama M; Hibiya K; Yamashiro T; Nakamatsu M; Tomoyose T; Nagahama M; Okamura T; Owan T; Kuda T; Kinjo F; Fujita J
    Jpn J Infect Dis; 2008 Sep; 61(5):371-4. PubMed ID: 18806344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
    Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
    J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. I. Antibody level for B pertussis antigens in children without respiratory tract infection symptoms].
    Chodorowska M
    Med Dosw Mikrobiol; 1999; 51(3-4):259-68. PubMed ID: 10803255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE; Lapé-Nixon M; Matud J
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and by intact bacteria.
    Craig FF; Lackie JM; Parton R; Freer JH
    J Gen Microbiol; 1988 Aug; 134(8):2201-11. PubMed ID: 2908118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.
    McGuirk P; Mills KH
    Eur J Immunol; 2000 Feb; 30(2):415-22. PubMed ID: 10671196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of filamentous hemagglutinin in the adherence of Bordetella pertussis to human WiDr cell cultures.
    Urisu A; Cowell JL; Manclark CR
    Dev Biol Stand; 1985; 61():205-14. PubMed ID: 2872106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate cyclase influences filamentous haemagglutinin-mediated attachment of Bordetella pertussis to epithelial alveolar cells.
    Perez Vidakovics ML; Lamberti Y; van der Pol WL; Yantorno O; Rodriguez ME
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):140-7. PubMed ID: 16965362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.
    Eby JC; Gray MC; Warfel JM; Merkel TJ; Hewlett EL
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27760780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental models for testing "Bordetella pertussis" virulence and immunogenicity.
    Alonso JM; Rocancourt M; Le Nin S; Brezin C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):319-27. PubMed ID: 2892512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.